Immunic Inc (IMUX) Stock Price, Quote, News & History

IMUXNASDAQ
$12.19
-0.55-4.32%
At close: Sep 8, 5:00 PM EST
$11.95
-0.79-6.2%
Pre-Market: 5:06 AM EST

Immunic (IMUX) Stock Price, Quote, News & History | Benzinga

Financials

Quarterly
Annual
Name
Revenue
Change
Gross
Change
EBITDA
Change
EBIT
Change
Earnings
Change

Cash Flows

Operating Cash Flow (TTM)
-87.72M
Investing Cash Flow (TTM)
-329.00K
Financing Cash Flow (TTM)
188.82M
Free Cash Flow (TTM)
-88.05M
Capital Expenditure (TTM)
-329.00K
Net Change in Cash (TTM)
100.77M

Analyst Trends and Forecast

1
Mar
2
Apr
1
May
1
Aug
1
Sep
Buy
Hold
Sell
Strong Sell

Analyst Rating and Forecast

12345
4.2
Buy
Strong Buy
Buy
Hold
Sell
Strong Sell

Valuation Metrics

Enterprise Value
$11.32M
PE Ratio (TTM)
-
PE Ratio (FWD)
-
PEG Ratio (TTM)
-
PS Ratio (TTM)
-
PB Ratio (TTM)
1.30
Earnings Yield % (TTM)
-29.21%
Earnings Yield % (FWD)
-21.88%
EV / EBITDA (TTM)
-
Price / EBITDA (TTM)
-
Price / Free Cash Flow (TTM)
-
Book Value / Share
$9.35

Company Debt

Total Debt
-
LT Debt
-
LT Debt Issuance (TTM)
-
LT Debt Repayment (TTM)
-
Total Cash
$155.10M
Debt to Equity
0.00
Issuance of Debt (TTM)
-
Repayment of Debt (TTM)
-

Key Statistics

Open
-
Close
$12.19
Volume / Avg.
589.00 / 203.36K
Day Range
- - -
52 Wk Range
5.06 - 17.43
Market Cap
$163.05M
P/E Ratio
-
Dividend Yield
-
Exchange
NASDAQ
RSI
29
Short Interest
9.9%
Days to Cover
7.01

About

Sector
Health Care
Industry
Biotechnology
Immunic Inc is a clinical-stage biopharmaceutical company developing a pipeline of selective oral immunology therapies aimed at treating chronic inflammatory and autoimmune diseases, including ulcerative colitis, Crohn's disease, relapsing-remitting ...
Show More
Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Compare

EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

FAQ

Q

How do I buy Immunic (IMUX) stock?

A

You can purchase shares of Immunic (NASDAQ:IMUX) through any online brokerage.

View our list of the best stock brokerages

Q

What is the forecast, or price target, for Immunic (IMUX) stock?

A

Immunic has a consensus price target of $15.77.

Q

What is the current price for Immunic (IMUX)?

A

The stock price for Immunic (NASDAQ: IMUX) is $11.95 last updated September 10, 2026 at 5:06 AM EDT.

Q

Does Immunic (IMUX) pay a dividend?

A

There are no upcoming dividends for Immunic.

Q

When is Immunic (NASDAQ:IMUX) reporting earnings?

A

Immunic does not have any upcoming earnings scheduled.

Q

Is Immunic (IMUX) going to split?

A

There is no upcoming split for Immunic.

Q

What sector and industry does Immunic (IMUX) operate in?

A

Immunic is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.